- call +1-201-465-4211
- email sales@mrinsights.biz
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
Scope of the Report:
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
The global Cardiac Biomarkers Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cardiac Biomarkers Testing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Cardiac Biomarkers Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cardiac Biomarkers Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
F. HOFFMANN-LA ROCHE LTD.
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Market Segment by Applications, can be divided into
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cardiac Biomarkers Testing Market Overview
1.1 Product Overview and Scope of Cardiac Biomarkers Testing
1.2 Classification of Cardiac Biomarkers Testing by Types
1.2.1 Global Cardiac Biomarkers Testing Revenue Comparison by Types (2019-2024)
1.2.2 Global Cardiac Biomarkers Testing Revenue Market Share by Types in 2018
1.2.3 Myocardial Muscle Creatine Kinase (CK-MB)
1.2.4 Troponins (T and I)
1.2.5 Myoglobin
1.2.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP
1.2.7 Ischemia-modified Albumin (IMA)
1.2.8 Others
1.3 Global Cardiac Biomarkers Testing Market by Application
1.3.1 Global Cardiac Biomarkers Testing Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Myocardial Infarction
1.3.3 Congestive Heart Failure
1.3.4 Acute Coronary Syndrome
1.3.5 Atherosclerosis
1.3.6 Others
1.4 Global Cardiac Biomarkers Testing Market by Regions
1.4.1 Global Cardiac Biomarkers Testing Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
1.5 Global Market Size of Cardiac Biomarkers Testing (2014-2024)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Cardiac Biomarkers Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.2 Becton, Dickinson and Company
2.2.1 Business Overview
2.2.2 Cardiac Biomarkers Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioMerieux
2.3.1 Business Overview
2.3.2 Cardiac Biomarkers Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.4 Bio-Rad Laboratories, Inc.
2.4.1 Business Overview
2.4.2 Cardiac Biomarkers Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.5 Danaher Corporation
2.5.1 Business Overview
2.5.2 Cardiac Biomarkers Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.6 F. HOFFMANN-LA ROCHE LTD.
2.6.1 Business Overview
2.6.2 Cardiac Biomarkers Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.7 Siemens AG
2.7.1 Business Overview
2.7.2 Cardiac Biomarkers Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Business Overview
2.8.2 Cardiac Biomarkers Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.9 PerkinElmer Inc.
2.9.1 Business Overview
2.9.2 Cardiac Biomarkers Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tosoh Corporation
2.10.1 Business Overview
2.10.2 Cardiac Biomarkers Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
3 Global Cardiac Biomarkers Testing Market Competition, by Players
3.1 Global Cardiac Biomarkers Testing Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Cardiac Biomarkers Testing Players Market Share
3.2.2 Top 10 Cardiac Biomarkers Testing Players Market Share
3.3 Market Competition Trend
4 Global Cardiac Biomarkers Testing Market Size by Regions
4.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Regions
4.2 North America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.3 Europe Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.5 South America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5 North America Cardiac Biomarkers Testing Revenue by Countries
5.1 North America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
5.2 USA Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5.3 Canada Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
5.4 Mexico Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6 Europe Cardiac Biomarkers Testing Revenue by Countries
6.1 Europe Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
6.2 Germany Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.3 UK Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.4 France Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.5 Russia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
6.6 Italy Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries
7.1 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
7.2 China Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.3 Japan Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.4 Korea Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.5 India Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8 South America Cardiac Biomarkers Testing Revenue by Countries
8.1 South America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
8.2 Brazil Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8.3 Argentina Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
8.4 Colombia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Cardiac Biomarkers Testing by Countries
9.1 Middle East and Africa Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
9.2 Saudi Arabia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.3 UAE Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.4 Egypt Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.5 Nigeria Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
9.6 South Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
10 Global Cardiac Biomarkers Testing Market Segment by Type
10.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Type (2014-2019)
10.2 Global Cardiac Biomarkers Testing Market Forecast by Type (2019-2024)
10.3 Myocardial Muscle Creatine Kinase (CK-MB) Revenue Growth Rate (2014-2024)
10.4 Troponins (T and I) Revenue Growth Rate (2014-2024)
10.5 Myoglobin Revenue Growth Rate (2014-2024)
10.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP Revenue Growth Rate (2014-2024)
10.7 Ischemia-modified Albumin (IMA) Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Cardiac Biomarkers Testing Market Segment by Application
11.1 Global Cardiac Biomarkers Testing Revenue Market Share by Application (2014-2019)
11.2 Cardiac Biomarkers Testing Market Forecast by Application (2019-2024)
11.3 Myocardial Infarction Revenue Growth (2014-2019)
11.4 Congestive Heart Failure Revenue Growth (2014-2019)
11.5 Acute Coronary Syndrome Revenue Growth (2014-2019)
11.6 Atherosclerosis Revenue Growth (2014-2019)
11.7 Others Revenue Growth (2014-2019)
12 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
12.1 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
12.2 Global Cardiac Biomarkers Testing Market Forecast by Regions (2019-2024)
12.3 North America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.4 Europe Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.6 South America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cardiac Biomarkers Testing Picture
Table Product Specifications of Cardiac Biomarkers Testing
Table Global Cardiac Biomarkers Testing and Revenue (Million USD) Marke
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
